View Older Stories View More Recent Stories
-
BG Medicine (BGMD) Prices Series A, B Units Offering at $1/Unit
-
BG Medicine Prices Underwritten Public Offering
-
BG Medicine Prices Underwritten Public Offering
-
Roth Capital Raises Price Target on SolarEdge Technologies (SEDG) Following EPS Beat
-
Leyard Optoelectronic to Acquire Planar Systems (PLNR) for $6.58/Share
-
Planar Agrees to Be Acquired by Leyard for $6.58 Per Share
-
BG Medicine (BGMD) Reports Underwritten Offering
-
BG Medicine Announces Proposed Underwritten Public Offering
-
BG Medicine Announces Proposed Underwritten Public Offering
-
Buy bluebird bio (BLUE) on Weakness Related to GBT IPO, Roth Capital Says
-
Roth Capital Cuts Price target to $35 on Daqo New Energy (DQ) Following 2Q15
-
Roth Capital Trims PT on JA Solar (JASO) to $8 Following Weak Q3 Guide
-
Nuverra Environmental Solutions (NES) Likely to See Crude Oil Headwinds in H215; Roth Affirms at 'Neutral'
-
Supermicro® Announces August and September 2015 Investor Conference Schedule
-
Roth Capital Raises Price on ICU Medical (ICUI) to $124 Following 2Q EPS Beat and Raise
-
Roth Capital Trims PT on Celldex (CLDX) to $39 Following Q2 Results; Would be Buyers on Weakness
-
Roth Capital Positive on Rexahn Pharma (RNN) Following Q2 Report; Upcoming Supinoxin, RX-3117 Phase 1 Data is Key
-
TG Therapeutics (TGTX) Continuing to Drive on All Cylinders; Roth Affirms 'Focus Pick' Rating
-
Roth Capital Cuts Price Target on Eco-stim Energy Solutions (ESES) to $7 Following 11c EPS Miss
-
InSite Vision Receives Unsolicited Proposal from a Multi-National Pharmaceutical Company
-
Roth Capital Cuts Price Target on Cytori Therapeutics (CYTX) Following 2Q Earnings Report
-
Roth Capital Cuts Price Target on Curis (CRIS) Following 2Q Results
-
Roth Capital Starts Omeros Corp. (OMER) at Buy
-
Roth Capital Downgrades Keryx Biopharmaceuticals (KERX) to Neutral
-
Intec Pharma Ltd. Announces Closing of U.S. Initial Public Offering
-
Roth Capital Cuts Price Target on Tangoe (TNGO) to $16 Following EPS Miss
-
Roth Capital Upgrades NVIDIA (NVDA) to Buy
-
Pixelworks (PXLW) Prices 3.25M Common Stock Offering at $4.75/Share
-
Pixelworks Announces Details of Common Stock Offering of 3.25 Million Shares with Gross Proceeds of $15.4 Million
-
Roth Capital Upgrades Planar Systems (PLNR) to Buy
-
Robust Margins Propel Plug Power (PLUG) to Mixed Q2 Results; Roth Affirms at 'Neutral'
-
Pixelworks (PXLW) to Offer Common Stock
-
Pixelworks Announces Public Offering of Common Stock
-
Roth Capital Cuts Price Target on Zumiez, Inc. (ZUMZ) Following Quarter Results
-
Roth Capital Cuts Price Target on Power Solutions (PSIX) to $75 Following In-Line EPS
-
Roth Capital Raises Price Target on Manitex Int'l (MNTX) to $8 Following 2Q15
-
Roth Capital Raises Price Target on PowerSecure (POWR) Following EPS Beat
-
Roth Capital Cuts Price Target on Apricus Biosciences (APRI) to $3 Following 2Q15
-
Roth Capital Cuts Price Target on Apricus Biosciences (APRI) to $3 Following 2Q15
-
SodaStream (SODA) Bullish Stance Reiterated at Roth Capital; Sees Gradual Recovery in 2nd-Half
-
Roth Remains Positive on SolarCity (SCTY) Following Q2 Results, M&A Outlook; Affirms at 'Buy'
-
Roth Capital Upgrades RSP Permian, Inc. (RSPP) to Buy
-
Sapiens International (SPNS) PT Bumped to $13 at Roth Capital Amid Strong Results
-
Notable Analyst Rating Changes 8/5: (MRVL) (JCP) (LXK) Upgraded; (AAPL) (ADSK) (VSH) Downgraded
-
Roth Capital Cuts Price Target on ZAGG, Inc. (ZAGG) Following 2Q EPS Beat
-
Roth Capital Downgrades TriMas Corp. (TRS) to Neutral
-
Roth Capital Raises Price Target on Masimo Corp. (MASI) to $46 Following 2Q Results and Guidance
-
Roth Capital Assumes Ideal Power (IPWR) at Buy
-
Roth Capital Downgrades Orion Energy Systems (OESX) to Neutral
-
Intec Pharma (NTEC) IPO Opens Flat
